Equivalence testing the easy way

Journal of Computing and Information Technology

Volumn 10, Issue 3, 2002, Pages 233-239

  Lužar Stiffler, Vesna ^a   Stiffler, Charles ^b  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b CAIR Research Centre   (Croatia)

Author keywords

Clinical trials; Crossover design; Equivalence testing; Nonparametric tests; SAS application; TOST

Indexed keywords

APPLICATION PROGRAMS; C (PROGRAMMING LANGUAGE); EQUIVALENCE CLASSES;

CLINICAL TRIAL; CROSSOVER DESIGN; EQUIVALENCE TESTING; NON-PARAMETRIC TEST; TOST;

SOFTWARE TESTING;

EID: 20444407450     PISSN: 13301136     EISSN: 18463908     Source Type: Journal    
DOI: 10.2498/cit.2002.03.12     Document Type: Article

References (11)

1. BERGER RL, HSU JC. Bioequivalence trials, Intersection-Union Tests and Equivalence Confidence Sets (with discussion). Statistical Science 1996; 11(4), 283-319.
2. CHEN, ML. Individual bioequivalence - a regulatory update. J. Biopharm. Stat. 1997; 7: 5-11.
3. CHOW, S-C, LIU J-P. Design and Analysis of Bioavailability and Bioequivalence Studies. New York: Marcel Dekker, Inc.; Second Edition; 2000.
4. EFRON, B. The Jackknife, Bootstrap and Other Resampling Plans. SIAM, Philadelphia; 1982.
5. FIELLER, E. Some problems in interval estimation. J. R. Stat. Soc. B 1954; 16: 175-185.
6. HAUSCHKE D., STEINIJANS VW., DILETTI E. A distribution-free procedure for the statistical analysis of bioequivalence studies. Int. J. Of Clin. Pharm., Therapy and Toxic., 1990; 28(2): 72-78.
7. SCHUIRMANN, DJ. On hypothesis testing to determine if the mean of a normal distribution is contained in a known interval. Biometrics 1981; 37:617.
8. SCHUIRMANN, DJ. A comparison of the two onesided tests procedure and the power approach for assessing the equivalence of average bioavailability. J. Pharmacokin. Biopharm. 1987; 15: 657-680.
9. SHAPIRO, SS., WILK MB. An analysis of variance test for normality (complete samples). Biometrika 1965; 52: 591-611.
10. Statistical Solutions Ltd., Ireland. EquivTest. http://www.statsol.ie/equivtest/ equivtest.html [3/30/2002].
11. US Food and Drug Administration (FDA). Guidance on Statistical Procedures for Bioequivalence Using a Standard Two-treatment Crossover Design. Division of Bioequivalence, Office of Generic Drugs, Center for Drug Evaluation and research, US Food and Drug Administration, Rockville, MD.; 1992.